Inflazome is a biotech company focusing on developing orally available drugs targeting inflammasomes to address various inflammatory diseases, including Parkinson's, Alzheimer's, atherosclerosis, and type 2 diabetes
Inflazome is a biotech company focusing on developing orally available drugs targeting inflammasomes to address various inflammatory diseases, including Parkinson's, Alzheimer's, atherosclerosis, and type 2 diabetes.